JAMA & Archives
SEARCH
GO TO ADVANCED SEARCH
-
HOME  SUBSCRIPTIONS  E-MAIL ALERTS  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP

Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 431-440 of 550 total displayed.

Past content

Arch Dermatol
Editorials
Autologous Fat Transplantation
Michael S. Kaminer; Nayomi E. Omura
Arch Dermatol 2001; 137: 812-814. [Extract] [Full text] [PDF]  

JAMA
Original Contributions
Novel Risk Factors for Systemic Atherosclerosis: A Comparison of C-Reactive Protein, Fibrinogen, Homocysteine, Lipoprotein(a), and Standard Cholesterol Screening as Predictors of Peripheral Arterial Disease
Paul M. Ridker; Meir J. Stampfer; Nader Rifai
JAMA 2001; 285: 2481-2485. [Abstract] [Full text] [PDF]  

JAMA
Special Communications
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
JAMA 2001; 285: 2486-2497. [Extract] [Full text] [PDF]  

JAMA
Editorials
Updated Guidelines for Cholesterol Management
Michael S. Lauer; Phil B. Fontanarosa
JAMA 2001; 285: 2508-2509. [Extract] [Full text] [PDF]  

JAMA
JAMA Patient Page
Cholesterol and Atherosclerosis
JAMA 2001; 285: 2536. [PDF] [ Key Words ]  

Arch Intern Med
Editorials
Primary Prevention of Coronary Heart Disease: Where Do We Go From Here?
Antonio M. Gotto Jr
Arch Intern Med 2001; 161: 922-924. [Extract] [Full text] [PDF]  

Arch Intern Med
Original Investigations
Applicability of Cholesterol-Lowering Primary Prevention Trials to a General Population: The Framingham Heart Study
Donald M. Lloyd-Jones; Christopher J. O'Donnell; Ralph B. D'Agostino; Joseph Massaro; Halit Silbershatz; Peter W. F. Wilson
Arch Intern Med 2001; 161: 949-954. [Abstract] [Full text] [PDF]  

JAMA
Original Contributions
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes: The MIRACL Study: A Randomized Controlled Trial
Gregory G. Schwartz; Anders G. Olsson; Michael D. Ezekowitz; Peter Ganz; Michael F. Oliver; David Waters; Andreas Zeiher; Bernard R. Chaitman; Sally Leslie; Theresa Stern; for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
JAMA 2001; 285: 1711-1718. [Abstract] [Full text] [PDF]  

JAMA
Editorials
Lipid-Lowering Therapy in Acute Coronary Syndromes
Frank M. Sacks
JAMA 2001; 285: 1758-1760. [Extract] [Full text] [PDF]  

JAMA
Original Contributions
Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events: VA-HIT: A Randomized Controlled Trial
Sander J. Robins; Dorothea Collins; Janet T. Wittes; Vasilios Papademetriou; Prakash C. Deedwania; Ernst J. Schaefer; Judith R. McNamara; Moti L. Kashyap; Jerome M. Hershman; Laura F. Wexler; Hanna Bloomfield Rubins; for the VA-HIT Study Group
JAMA 2001; 285: 1585-1591. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55

 Collections
 •Topic Collections Home
 •Related collections:
  •Nutritional and Metabolic Disorders
  •Lipids and Lipid Disorders
  •Malabsorption Syndromes
  •Metabolic Diseases
  •Metabolism
  •Nutrition/ Malnutrition
  •Nutritional and Metabolic Disorders, Other
Advertisement




HOME | SUBSCRIPTIONS | E-MAIL ALERTS | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.